孕期实施生活方式干预以降低妊娠期糖尿病和2型糖尿病发病率的长期成本效益
本研究采用决策分析马尔可夫模型,比较孕期结构化生活方式干预与常规产前保健在澳大利亚所有分娩女性中的长期成本效益。模型预测干预可使后续诊断为2型糖尿病的女性数量减少10%,从医疗保健角度干预具有优势(节约成本),每投入1澳元回报1.22澳元(95%CI 0.53, 2.13)。
要点
- 孕期结构化生活方式干预预计使后续2型糖尿病诊断女性数量减少10%。
- 从医疗保健角度干预具有优势(节约成本),每投入1澳元回报1.22澳元(95%CI 0.53, 2.13)。
核心结论
- 孕期实施结构化生活方式干预可显著节约成本,归因于女性围产期及终生不良健康结局的减少。
研究设计与样本
- 决策分析马尔可夫模型,比较结构化孕期生活方式干预与当前常规产前保健,针对澳大利亚所有分娩女性,采用生命表模型在终生时间范围捕捉2型糖尿病患病、死亡和质量调整生命年,成本纳入医疗保健和社会视角,干预效应源自已发表的Meta分析,并采用确定性和概率敏感性分析。
主要发现
- 模型预测干预组后续诊断为2型糖尿病的女性数量较常规保健组减少10%。
- 从医疗保健角度干预相对于常规保健具有优势(节约成本),每投入1澳元回报1.22澳元(95%CI 0.53, 2.13)。
- 结果对敏感性分析稳健,在所有探索情景中均保持节约成本或高度成本效益。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this study was to determine the long-term cost-effectiveness and return on investment of implementing a structured lifestyle intervention to reduce excessive gestational weight gain and associated incidence of gestational diabetes mellitus (GDM) and type 2 diabetes mellitus. METHODS: A decision-analytic Markov model was used to compare the health and cost-effectiveness outcomes for (1) a structured lifestyle intervention during pregnancy to prevent GDM and subsequent type 2 diabetes; and (2) current usual antenatal care. Life table modelling was used to capture type 2 diabetes morbidity, mortality and quality-adjusted life years over a lifetime horizon for all women giving birth in Australia. Costs incorporated both healthcare and societal perspectives. The intervention effect was derived from published meta-analyses. Deterministic and probabilistic sensitivity analyses were used to capture the impact of uncertainty in the model. RESULTS: The model projected a 10% reduction in the number of women subsequently diagnosed with type 2 diabetes through implementation of the lifestyle intervention compared with current usual care. The total net incremental cost of intervention was approximately AU$70 million, and the cost savings from the reduction in costs of antenatal care for GDM, birth complications and type 2 diabetes management were approximately AU$85 million. The intervention was dominant (cost-saving) compared with usual care from a healthcare perspective, and returned AU$1.22 (95% CI 0.53, 2.13) per dollar invested. The results were robust to sensitivity analysis, and remained cost-saving or highly cost-effective in each of the scenarios explored. CONCLUSIONS/INTERPRETATION: This study demonstrates significant cost savings from implementation of a structured lifestyle intervention during pregnancy, due to a reduction in adverse health outcomes for women during both the perinatal period and over their lifetime.
引用
- Lloyd M, Morton J, Teede H, et al. Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes. Diabetologia. 2023. PMID: 36932207. doi:10.1007/s00125-023-05897-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。